Latus Bio
Philadelphia
About Latus Bio
Latus Bio focuses on developing innovative gene therapy candidates using precision delivery to enhance the lives of patients. Latus identified proprietary AAV capsids for clinical use. The company plans to administer low doses of its product candidates, aiming to improve clinical safety and manufacturing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $54.0M
- Funding stage: Early Stage Venture
- Last round: Series A (May 2024)
- Website: latusbio.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Genetics
Social Profiles
Canonical: https://fsome.com/organization/latus-bio-53476 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.